Health Care • Medical Electronics
$0.31 ▼ -0.02
(-4.82%)
MKT CAP: $24.0M • VOL: 1.25M
52W L $0 52W H $5
NNOX // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $13.0M | $11.3M | $9.9M |
| YoY Revenue Growth % | +15.4% | +13.9% | — |
| Gross Profit | -$12.8M | -$10.6M | — |
| Gross Margin % | -50.0% | -50.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$78.2M | -$56.7M | -$62.6M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$75.0M | -$53.5M | -$60.8M |
| EBITDA (Normalized) | -$74.9M | -$54.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$40.8M | -$36.6M | -$44.8M |
| Capital Expenditures (CapEx) | $4.2M | $2.8M | — |
| Free Cash Flow (FCF) | -$45.0M | -$39.4M | -$44.8M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -29.9% | — |
| Cash & Short-Term Equivalents | $49.2M | $39.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $139.7M | $189.1M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR NNOX.